Skip to content
Physician-backed infrastructure for aesthetic & wellness practicesSupport 9 AM–5 PM EST ·(888) 996-6173 ·info@medgrid.com
MedGrid
FDA Daily

FDA daily for Friday, October 9, 2026

55 FDA records across 3 sections. 1 touches MedGrid's categories and is listed first.

55FDA Records
3 of 7Sections With Data
1Touch MedGrid Categories

Sections in This Issue

Drug shortagesCovers FDA's Thu, Oct 8 (yesterday)
1 touch MedGrid22
  • Lidocaine Hydrochloride InjectionTouches MedGrid categories

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) — Spectra Medical Devices, LLC

    Reverified · Current · Anesthesia

  • Clindamycin Phosphate Injection

    Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) — Sandoz Inc.

    Reverified · Current · Anti-Infective

  • Ketorolac Tromethamine Injection

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) — Sagent Pharmaceuticals

    Reverified · Current · Analgesia/Addiction

  • Clindamycin Phosphate Injection

    Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) — Sandoz Inc.

    Reverified · Current · Anti-Infective

  • Ketorolac Tromethamine Injection

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) — Sagent Pharmaceuticals

    Reverified · Current · Analgesia/Addiction

  • Rocuronium Bromide Injection

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) — Sagent Pharmaceuticals

    Reverified · Current · Anesthesia

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01) — Sandoz Inc.

    Reverified · Current · Psychiatry

  • Clindamycin Phosphate Injection

    Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) — Sagent Pharmaceuticals

    Reverified · Current · Anti-Infective

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01) — Sandoz Inc.

    Reverified · Current · Psychiatry

  • Clindamycin Phosphate Injection

    Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) — Sagent Pharmaceuticals

    Reverified · Current · Anti-Infective

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01) — Sandoz Inc.

    Reverified · Current · Psychiatry

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01) — Sandoz Inc.

    Reverified · Current · Psychiatry

Showing 12 of 22. Search the rest in openFDA.

Drug approvalsCovers FDA's Fri, Oct 2 (a week ago)
12
  • DOXERCALCIFEROL

    DOXERCALCIFEROL — HIKMA

    ANDA091433 · Labeling

  • EXENATIDE SYNTHETIC

    EXENATIDE SYNTHETIC — AMNEAL

    ANDA206697 · Labeling

  • CLOZAPINE

    CLOZAPINE — MYLAN

    ANDA075417 · Labeling

  • CLOZAPINE

    CLOZAPINE — ACCORD HLTHCARE

    ANDA202873 · Labeling

  • JAYPIRCA

    PIRTOBRUTINIB — LOXO ONCOL

    NDA216059 · Efficacy

  • METHYLPHENIDATE HYDROCHLORIDE

    METHYLPHENIDATE HYDROCHLORIDE — ALVOGEN

    ANDA206840 · Labeling

  • CYPROHEPTADINE HYDROCHLORIDE

    CYPROHEPTADINE HYDROCHLORIDE — QUAGEN

    ANDA212491 · Manufacturing (CMC)

  • DIVALPROEX SODIUM

    DIVALPROEX SODIUM — COSETTE PHARMS NC

    ANDA078700 · Labeling

  • PERAMPANEL

    PERAMPANEL — AUROBINDO PHARMA LTD

    ANDA220492 · Original approval

  • CELECOXIB

    CELECOXIB — UNICHEM

    ANDA213301 · Labeling

  • FOSAPREPITANT DIMEGLUMINE

    FOSAPREPITANT DIMEGLUMINE — BAXTER HLTHCARE CORP

    ANDA211860 · Labeling

  • EXCEDRIN (MIGRAINE RELIEF)

    ACETAMINOPHEN, ASPIRIN, CAFFEINE — HALEON US HOLDINGS

    NDA020802 · Labeling

Drug recallsCovers FDA's Fri, Oct 2 (a week ago)
Nothing from FDA for this date
Food and supplement recallsCovers FDA's Fri, Oct 2 (a week ago)
Nothing from FDA for this date
Device recallsCovers FDA's Fri, Oct 2 (a week ago)
Nothing from FDA for this date
Device clearancesCovers FDA's Fri, Sep 25 (two weeks ago)
21
  • syngo.CT Brain Quantification

    Siemens Medical Solutions USA, Inc.

    K260055 · Substantially Equivalent · Radiology

  • Braun Aura 9 (6042)

    Cyden Limited

    K261977 · Substantially Equivalent · General, Plastic Surgery

  • REBOHIL (BGM-1, BGM-2, BGM-3, BGM-4, BGM-5)

    Hyundai Bioland Co., Ltd.

    K254210 · Substantially Equivalent · Dental

  • Xpert Respiratory Panel

    Cepheid

    K261336 · Substantially Equivalent · Microbiology

  • Profoject™ Safety Sliding Blood Collection Set

    CMT Health PTE., Ltd.

    K262215 · Substantially Equivalent · Clinical Chemistry

  • Arthrex Beaming System

    Arthrex, Inc.

    K262975 · Substantially Equivalent · Orthopedic

  • DistaSense(TM) (v1)

    Life Detection Technologies

    K254058 · Substantially Equivalent · Cardiovascular

  • UNIDRIVE SIII System; HOPKINS Telescope 0º (26205AMA) Operating Sheath (26205CD) Obturator (26205OC) Shaver Blade (2620…

    Karl Storz SE & CO. KG

    K254252 · Substantially Equivalent · Obstetrics/Gynecology

  • S-Patch CardioAI

    Wellysis Corp.

    K254255 · Substantially Equivalent · Cardiovascular

  • CapsoView (CVV); CapsoCloud (CLD)

    CapsoVision, Inc.

    K254230 · Substantially Equivalent · Gastroenterology, Urology

  • Altis Full Face Mask

    Respironics, Inc.

    K261262 · Substantially Equivalent · Anesthesiology

  • TumorSight Risk

    SimBioSys, Inc.

    K260023 · Substantially Equivalent · Pathology

Showing 12 of 21. Search the rest in openFDA.

Label changesCovers FDA's Fri, Sep 25 (two weeks ago)
Nothing from FDA for this date
How the FDA Daily Is WrittenSources, dates and what gets flagged

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.

Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.